Clinical Trial Spotlight: Asthma Research Study
Researchers are conducting a study to test the safety of a type of asthma medication called formoterol, a component of Symbicort, when it is taken in combination with inhaled corticosteroids to find out if the addition of an inhaled corticosteroid, such as budesonide, reduces the increased risk of asthma-related hospitalizations and death from formoterol.
They are looking for adolescents and adults, aged 12 years and older, who have been diagnosed with asthma. Participants will be compensated for study-related time and travel.
For more information, contact the research coordinator at 513-558-5795 or 513-558-0924.
Tags
Related Stories
Can new rules in Ohio address a pharmacy staffing shortage and...
May 17, 2024
The University of Cincinnati's Michael Hegener joined WVXU's Cincinnati Edition to discuss recent rules released by the Ohio Board of Pharmacy designed to address pharmacy staffing.
Is ketamine the answer to treatment-resistant depression?
May 16, 2024
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.
UC study: Severe ischemic strokes rare in total patient...
May 15, 2024
The University of Cincinnati’s Yasmin Aziz will present research at the European Stroke Organisation Conference that found severe ischemic strokes with the most severe damage are rare in the total stroke patient population.